A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex. (2023)

First Author: Eastwood MC
Attributed to:  United Kingdom Refractory Asthma Stratification Programme (RASP-UK) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaip.2022.12.019

PubMed Identifier: 36621603

Publication URI: http://europepmc.org/abstract/MED/36621603

Type: Journal Article/Review

Volume: 11

Parent Publication: The journal of allergy and clinical immunology. In practice

Issue: 4